Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson and Johnson To Retire, Effective December 31, 2021

NEW BRUNSWICK, N.J., Oct. 12, 2021 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson (NYSE: JNJ) today announced that Paul Stoffels M.D., currently Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson, wi... Biopharmaceuticals, Personnel Johnson & Johnson
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news